Abstract
Increased consumption of high-caloric diets combined with reduced physical activity are the main causes for the worldwide dramatic increase in the metabolic syndrome. Obesity (Chap. 8) and insulin resistance (Chap. 9) is initiating the development of the metabolic syndrome, and both significantly increase the risk of T2D (Chap. 10) and CVD (Chap. 11). Insulin plays a central role in regulating energy homeostasis in metabolic tissues. The effects of hyperglycemia and insulin resistance on the risk of CVD are largely pathway- and tissue-specific. The genetic risk for the metabolic syndrome overlaps with that of its major components, such as obesity, T2D and dyslipdemia, but like in these traits, common genetic variations can explain only a minor part of the disease risk. However, there is emerging evidence for an important role of epigenetics, causing heritable changes in gene expression, in the origin and development of the metabolic syndrome.
In this chapter, we discuss the role of insulin resistance and obesity in the major metabolic tissues liver, skeletal muscle, pancreas and WAT causing the metabolic syndrome. We will emphasize pathways that are involved in energy metabolism and will describe how insulin resistance and obesity lead to the metabolic syndrome and its complications. The importance of inflammation and regulation of energy metabolism will be highlighted. In addtion, we will discuss the future challenges and possibilities to treat and prevent the metabolic syndrome by dietary modifications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Additional Reading
Desai M, Jellyman JK, Ross MG (2015) Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) 39(4)
Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–917
Huang PL (2009) A comprehensive definition for metabolic syndrome. Dis Model Mech 2:231–237
Keane D, Kelly S, Healy NP, McArdle MA, Holohan K, Roche HM (2013) Diet and metabolic syndrome: an overview. Curr Vasc Pharmacol 11:842–857
Lusis AJ, Attie AD, Reue K (2008) Metabolic syndrome: from epidemiology to systems biology. Nat Rev Genet 9:819–830
Nature Medicine: www.nature.com/nm/e-poster/eposter_full.html
Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J (2012) Metabolic syndrome: evidences for a personalized nutrition. Mol Nutr Food Res 56:67–76
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Carlberg, C., Ulven, S.M., Molnár, F. (2016). The Metabolic Syndrome. In: Nutrigenomics. Springer, Cham. https://doi.org/10.1007/978-3-319-30415-1_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-30415-1_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30413-7
Online ISBN: 978-3-319-30415-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)